Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.510
-0.030 (-0.85%)
At close: Apr 2, 2026, 4:00 PM EDT
3.229
-0.281 (-8.02%)
After-hours: Apr 2, 2026, 5:43 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $165.66 million as of April 2, 2026. Its market cap has increased by 77.36% in one year.
Market Cap
165.66M
Enterprise Value
19.96M
1-Year Change
77.36%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $165.66M, a decrease of -69.37%. That is a compound annual growth rate of -22.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 165.66M | 45.25% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 173.35M |
| Protalix BioTherapeutics | 173.23M |
| Achieve Life Sciences | 171.97M |
| Milestone Pharmaceuticals | 169.26M |
| Connect Biopharma Holdings | 169.00M |
| Canton Strategic Holdings | 167.95M |
| Artiva Biotherapeutics | 166.59M |
| Cartesian Therapeutics | 165.95M |